A detailed history of Credit Agricole S A transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Credit Agricole S A holds 13,606 shares of NBIX stock, worth $1.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,606
Previous 7,206 88.81%
Holding current value
$1.71 Million
Previous $993,000 88.62%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$130.86 - $143.19 $837,504 - $916,416
6,400 Added 88.81%
13,606 $1.87 Million
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $939,662 - $1.04 Million
7,206 New
7,206 $993,000
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $43,090 - $49,515
-500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$87.57 - $119.4 $43,785 - $59,700
500 New
500 $49,000
Q4 2017

Feb 13, 2018

SELL
$58.53 - $77.59 $58,530 - $77,590
-1,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
1,000
1,000 $46,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.